Report number:
54/2022

Abbreviated name of the issuer: 
MIRBUD S.A.

Subject:
Selection of bid for the construction of a radiotherapy building for the Medical University of Łódź 

Legal basis:
Article 17(1) MAR – Confidential information

Report content:    

The Management Board of MIRBUD S.A. (hereinafter referred to as the “Issuer”), acting in accordance with Article 17(1) of the MAR, informs that on 22 August 2022 it received information from the Contracting Authority, the Medical University of Łódź (Al. Kościuszki 4, 90-419 Łódź), that the Issuer’s bid was selected as the most advantageous one in the tender procedure, conducted in the open tender procedure, titled “Construction of the Radiotherapy Building as part of the Second Stage of the Clinical and Didactic Centre of the Medical University of Łódź with the Academic Oncology Centre – building shell including landscaping”.

Bid value:  PLN 39,595,478,40 gross.

The Issuer will inform about signing of the Contract in a separate report.

The information on the selection of the bid has been qualified by the Issuer as confidential information, as defined in Article 7 of the Regulation (EU) No. 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC (OJ EU L 173, 12.06.2014, hereinafter referred to as the “MAR”), due to the significant value of the bid on the scale of the Company and its importance for the Issuer.

Signatures of representatives:

Jerzy Mirgos – President of the Management Board                                   
Paweł Korzeniowski – Member of the Management Board